H.C. Wainwright Reiterates Buy Rating on CG Oncology (CGON)

July 29, 2026 6:49 AM

H.C. Wainwright analyst Andres Maldonado reiterated a Buy rating and $100.00 price target on CG Oncology (NASDAQ: CGON).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found